ATH Price sensitive 9 Jul 2026, 3:52 PM

ATH Receives A$3.98m R&D Tax Incentive

Alterity Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in